Investing
PepsiCo’s Margin Trends: Navigating Tariff Costs and Future Expectations
PepsiCo, Inc. (PEP) reported its third-quarter results on Dec. 8, 2025, facing ongoing margin pressures amid a challenging cost environment. The company’s core gross ...
2026 Quantum Competition: How IBM and Amazon Outshine Pure-Play Tech Companies
In 2025, pure-play quantum computing stocks such as Rigetti Computing (RGTI) and D-Wave Quantum (QBTS) initially saw significant returns, with QBTS rising 157% and ...
Comparing SoFi and Nu Holdings: Which Fintech Stock Offers the Best Investment Opportunity?
SoFi Technologies (SOFI) reported robust third-quarter 2025 results, achieving a record $277 million in adjusted EBITDA, a 29% margin, and total loan originations of ...
Three Semiconductor Stocks Set to Thrive in 2026
**Semiconductor Stocks Surge Amid Market Challenges** In 2025, semiconductor stocks have rallied significantly, with the iShares Semiconductor ETF (SOXX) showing a 43% increase year-to-date. ...
Top AI Stocks to Consider for Investment in 2026
AI capital spending is projected to reach approximately $571 billion by 2026, with key companies Nvidia (NVDA), Broadcom (AVGO), and Vertiv (VRT) positioned at ...
Top Cosmetics Stocks to Monitor in Anticipation of the 2026 Market Shift
The Zacks Cosmetics industry is currently facing significant challenges, including softer consumer spending and rising operational costs, which have collectively squeezed profit margins. Companies ...
Wells Fargo Stock Reaches 52-Week High: Potential for Further Growth?
Wells Fargo & Company (WFC) reached a new 52-week high of $94.68 on October 23, 2025, closing at $94.47. This surge was fueled by ...
Comparing HIMS and TDOC: Which Telehealth Investment Offers Greater Potential?
Hims & Hers Health, Inc. (HIMS) and Teladoc Health, Inc. (TDOC) are at the forefront of expanding virtual healthcare. HIMS operates a subscription-based telehealth ...
Quantum Sector Set for Over 40% Growth by 2026: Key Players INTC, AVGO, and TER
The quantum hardware sector, including companies like IonQ and D-Wave, is viewed as a long-term prospect. Analysts note these firms are securing government contracts ...
GILD Secures Licensing Rights for Assembly Bio’s Herpes Programs
Gilead Sciences (GILD) has exercised its option to exclusively license Assembly Biosciences’ (ASMB) herpes simplex virus (HSV) helicase-primase inhibitor programs, including investigational candidates ABI-1179 ...
